Moves to make hospital-grade technologies available for detecting early signs of vision-threatening eye diseases such as Glaucoma in optometry clinics to improve health outcomes and Glaucoma treatments during National Glaucoma Awareness month.
17 Jan 2019
11 Jan 2019
Medical device firm SightGlass Vision has started enrolling children aged between six and nine years at its multicenter trial designed to assess novel eyeglasses to control nearsightedness.
08 Jan 2019
BioTime has entered into a research and option agreement with Orbit Biomedical to access new device for the sub-retinal delivery of OpRegen cells for the treatment of dry age-related macular degeneration (dry-AMD).
04 Jan 2019
FUJIFILM Cellular Dynamics (FCDI), a subsidiary of FUJIFILM, is investing $21m to open a new cGMP-compliant production facility for production of human induced pluripotent stem (iPS) cell technologies.
21 Dec 2018
Beaver-Visitec International (BVI) has agreed to acquire Belgium-based ophthalmic firm PhysIOL Group for an undisclosed sum.
18 Dec 2018
Notal Vision has announced the achievement of a significant milestone in its plan to develop and commercialize a home-based, patient-operated, spectral-domain optical coherence tomography (SD-OCT) system.
13 Dec 2018
Glaukos, an ophthalmic medical technology, has published positive results from new study on iStent inject Trabecular Micro-Bypass System.
04 Dec 2018
Implandata Ophthalmic Products has implanted the first patient with its EYEMATE-SC, a new pressure sensor for continual monitoring of intraocular pressure (IOP).
29 Oct 2018
Clinical-stage biopharma company GenSight Biologics said that the first patient has been treated in a first-in-man trial assessing its gene therapy candidate, GS030-DP, in combination with a wearable optronic visual stimulation device, GS030-MD.
26 Oct 2018
Medical device firm NovioSense has reported positive data from its NLNSGS2017-02 phase 2 study of tear glucose sensor device and started a second follow up trial.